Peter Hanson
Chief Veterinary Officer
Biotechnology
Centrexion Therapeutics
United States of America
Biography
Peter Hanson joined Centrexion Therapeutics as the chief veterinary officer in June 2014. Peter also has responsibility for chemistry, manufacturing and controls (CMC) and clinical operations. He is a Diplomate of the American College of Veterinary Surgeons with nearly 20 years in pharmaceutical medicine. Prior to Centrexion, Peter was the head of research and development and medical affairs for Abbott Animal Health. From 1996 to 2012 he worked at Merial, most notably serving as the global head, project and portfolio management, the head of pharmaceutical R&D and the executive director, pharmaceutical R&D projects. Peter holds a B.A. in biology and a DVM from the University of Minnesota. He holds a residency certificate, an M.S. and Ph.D. in veterinary science from the University of Wisconsin-Madison.
Research Interest
Hias research interests : veterinary sciences ,Animal Health, phaarmaceutics